ReviewInternational journal of health sciences

A systematic review and meta-analysis of randomized controlled trials, juxtaposing the control of glycemia and blood pressure between large dose empagliflozin and placebo among type 1 diabetes patients.

Sumanta Saha et al.PubMed ↗Full text ↗

No numbers read from the abstract.